Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tichy

Showing results (1041-1050 of 1,052) with videos related to

Pageof 106
Sort By:
The Lancet. Haematology|November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trialHartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Radiation Research|February 21, 2017
Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO ExerciseH Dörr, M Abend, W F Blakely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Blood|March 15, 2012
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapiesAndreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
American Journal of Human Genetics|October 26, 2023
An autosomal-dominant childhood-onset disorder associated with pathogenic variants in VCPAnnelise Y Mah-Som, Jil Daw, Diana Huynh, et al.
Frontiers in Pharmacology|April 11, 2020
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and ImplicationsNenad Miljković, Brian Godman, Milena Kovačević, et al.
Radiation Research|April 5, 2023
RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome AssayD Endesfelder, U Oestreicher, M Bucher, et al.
Scientific Reports|March 18, 2021
Trends and outcomes for non-elective neurosurgical procedures in Central Europe during the COVID-19 pandemicLukas Grassner, Ondra Petr, Freda M Warner, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 106

Showing results (1041-1050 of 1,052) with videos related to

Sort By:
Pageof 106
The Lancet. Haematology|November 3, 2022
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trialHartmut Goldschmidt, Elias K Mai, Uta Bertsch, et al.
Radiation Research|February 21, 2017
Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO ExerciseH Dörr, M Abend, W F Blakely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Blood|March 15, 2012
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapiesAndreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
American Journal of Human Genetics|October 26, 2023
An autosomal-dominant childhood-onset disorder associated with pathogenic variants in VCPAnnelise Y Mah-Som, Jil Daw, Diana Huynh, et al.
Frontiers in Pharmacology|April 11, 2020
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and ImplicationsNenad Miljković, Brian Godman, Milena Kovačević, et al.
Radiation Research|April 5, 2023
RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome AssayD Endesfelder, U Oestreicher, M Bucher, et al.
Scientific Reports|March 18, 2021
Trends and outcomes for non-elective neurosurgical procedures in Central Europe during the COVID-19 pandemicLukas Grassner, Ondra Petr, Freda M Warner, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 106